Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00266526
Recruitment Status : Completed
First Posted : December 19, 2005
Last Update Posted : March 4, 2013
Information provided by (Responsible Party):
Allergopharma GmbH & Co. KG

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2004
  Actual Study Completion Date : July 2005